Christopher Nixon Cox
Board Member
Alto Neuroscience, Inc. (ANRO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher Nixon Cox
Christopher Nixon Cox is recorded as Board Member at Alto Neuroscience, Inc. (ANRO). Alto Neuroscience, Inc. reported in an 8-K filed August 13, 2025 that Christopher Nixon Cox was appointed Class III director, effective August 12, 2025. Alto Neuroscience, Inc. reported in an 8-K filed August 13, 2025 that Christopher Nixon Cox resigned as Class II director, effective August 12, 2025.
“Immediately following such resignations, the Board appointed Messrs. Dreyfus and Cox as Class I and Class III directors, respectively.”
“on August 12, 2025, Andrew Dreyfus and Christopher Nixon Cox resigned as Class III and Class II directors, respectively.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-08-12–present
-
Start not stated–2025-08-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alto Neuroscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Amit Etkin CEO, Board Member
- Nicholas Smith CFO
- Michael Hanley COO
- Andrew Dreyfus Board Member
- Andrew Miller, Ph.D. Board Member
- Gwill York Board Member
- Husseini Manji Board Member
- Maha Radhakrishnan, M.D. Board Member
- Ramiro (Raymond) Sanchez, M.D. Board Member
- Raymond Sanchez Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.